NCT01416116View on ClinicalTrials.gov

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

July 6, 2011

Primary Completion Date

April 25, 2012

Study Completion Date

April 25, 2012

Conditions
or Peripheral Nerve Injury (PNI)Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)
Interventions
DRUG

QUTENZA

topical

DRUG

Lidocaine

topical

DRUG

Tramadol

oral

Trial Locations (20)

Unknown

Site 102, Antwerp

Site 103, Genk

Site 101, Roeselare

Site 202, Hradec Králové

Site 203, Olomouc

Site 201, Prague

Site 302, Aalborg

Site 301, Aarhus

Site 402, Cork

Site 403, Galway

Site 404, Galway

Site 401, Limerick

Site 502, Hamar

Site 501, Skien

Site 603, Košice

Site 602, Martin

Site 702, Glasgow

Site 701, Liverpool

Site 704, Manchester

Site 703, Solihull

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY